Related Articles
Novel therapies for malignant pleural effusion: Anti‑angiogenic therapy and immunotherapy (Review)
Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non‑squamous non-small‑cell lung cancer
Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion
The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications (Review)
Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion